ReviewAnnals of medicine and surgery (2012)2026
Trial sequential analysis of the efficacy of amino acid and protein therapy in preventing cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis.
Review in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Acute kidney injury (AKI) is a common complication after cardiac surgery, with varying severity and outcomes. Despite studies on corticosteroids, remote ischemic preconditioning, and amino acid therapies like glutamate, results have remained inconsistent. This review aims to clarify the therapeutic role of intravenous amino acids in improving outcomes of cardiac surgery-related AKI. Methods: This systematic review followed PRISMA guidelines, analyzing studies on intravenous amino acids to prevent cardiac surgery-associated AKI. Databases were searched using MeSH terms, and strict inclusion criteria were applied. Data extraction, risk-of-bias assessment, and meta-analysis were conducted with standardized tools, including RevMan and TSA, to ensure reliability and statistical validity. Results: This meta-analysis included eight studies (seven RCTs and one cohort) evaluating amino acid/protein administration, with over 5000 participants per group. Results showed a non-significant trend toward reduced AKI risk (RR = 0.80, 95% CI: 0.63-1.02; Conclusion: Intraoperative amino acid/protein administration may reduce the risk of AKI and the need for renal replacement therapy, although this intervention appears to have limited impact on mortality or other complications. The observation of shorter hospital stays is promising, but further research is needed to standardize protocols and understand the underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.